Cargando…
Treatment of Connective Tissue Disease-Related Intractable Disease with Biological Therapeutics
The treatment of connective tissue disease (CTD) and CTD-related intractable diseases (CTD-IDs) currently depends on the use of steroid therapy. Approximately 20 years have passed since the approval of infliximab for rheumatoid arthritis in 2003. Since then, several biological therapeutics have been...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487282/ https://www.ncbi.nlm.nih.gov/pubmed/34611450 http://dx.doi.org/10.2147/OARRR.S328211 |